Although excessive angiotensin II is responsible for the exacerbation of COVID-19, yet the reduction of angiotensin II or blocking RAS pathway is able to limit the severity of acute lung injury caused by SARS-CoV-2 infection. This evidence concerns the gene AGT and COVID-19.